Caricamento...
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants have been used for over a century, to date, only few adjuvants are approved for human use, mostly aimed at improving vaccine efficacy and antigen-specific protective antibody production. The mechanism of actio...
Salvato in:
| Pubblicato in: | Vaccines (Basel) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494261/ https://ncbi.nlm.nih.gov/pubmed/26344622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines2020323 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|